Patent 8722669 was granted and assigned to Case Western Reserve University on May, 2014 by the United States Patent and Trademark Office.
A method of treating an ocular disorder in a subject associated with aberrant all-trans-retinal clearance in the retina, the method comprising administering to the subject a therapeutically effective amount of a primary amine compound of formula: